Fundraising FoxAmerica's Frontier Fund — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing.
Advanced ManufacturingBiotechHealthtechMenlo Park, US
Christina Smolke(Founder)inKristy Hawkins(Founder)inEric d'Esparbes(Chief Financial Officer)inZack McGahey(Chief Operating Officer)inHeidi Pucel(Chief People Officer)in
BoardRam Shriram(Director)
Co-investorsCivilization Ventures Management, LlcGlobal Health Investment CorporationIn-Q-TelLam CapitalSherpalo VenturesWestern Technology Investment
OmniBuds develops ear-worn biosensing earbuds that continuously monitor cardiovascular and physiological signals through AI-powered analysis.
AI & Machine LearningDeep TechDigital HealthHardwareHealthtechMedical DevicesNashville, US
Ben Carter(Founder)inFahim Kawsar(Founder)inAlessandro Montanari(Founder)inBenedict Carter(Executive Officer, Director)Joseph Caradonna(Director)Jeffrey Karras(Director)
Reimagining underground power transmission through self-propelled cable systems.
Berkeley, US
Zac Judkins(Founder)inZachary Judkins(Executive Officer, Director)
BoardJack Peurach(Director)
Co-investorsBlindspot Ventures Management CoNucleation CapitalRoadrunner VenturesZero Index
.jpeg){kind=logo}
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.